Dynamic Contrast‐Enhanced MRI Parameters and Normalized ADC Values Could Aid Differentiation of Skull Base Osteomyelitis from Nasopharyngeal Cancer

References

1. 1.↵
   1. Johnson AK,
   2. Batra PS

   . Central skull base osteomyelitis: an emerging clinical entity. Laryngoscope 2014;124:1083–87 doi:10.1002/lary.24440 pmid:24115113

   CrossRefPubMed
2. 2.↵
   1. Álvarez Jáñez F,
   2. Barriga LQ,
   3. Iñigo TR, et al

   . Diagnosis of skull base osteomyelitis. Radiographics 2021;41:156–74 doi:10.1148/rg.2021200046 pmid:33411616

   CrossRefPubMed
3. 3.↵
   1. Chang PC,
   2. Fischbein NJ,
   3. Holliday RA

   . Central skull base osteomyelitis in patients without otitis externa: imaging findings. AJNR Am J Neuroradiol 2003;24:1310–16 pmid:12917118

   PubMedWeb of Science
4. 4.↵
   1. Khan M,
   2. Quadri S,
   3. Kazmi A, et al

   . A comprehensive review of skull base osteomyelitis: diagnostic and therapeutic challenges among various presentations. Asian J Neurosurg 2018;13:959–70 doi:10.4103/ajns.AJNS_90_17 pmid:30459850

   CrossRefPubMed
5. 5.↵
   1. Auinger AB,
   2. Dahm V,
   3. Stanisz I, et al

   . The challenging diagnosis and follow-up of skull base osteomyelitis in clinical practice. Eur Arch Otorhinolaryngol 2021;278:4681–88 doi:10.1007/s00405-020-06576-6 pmid:33511482

   CrossRefPubMed
6. 6.↵
   1. van Kroonenburgh AM,
   2. van der Meer WL,
   3. Bothof RJ, et al

   . Advanced imaging techniques in skull base osteomyelitis due to malignant otitis externa. Curr Radiol Rep 2018;6:3 doi:10.1007/s40134-018-0263-y pmid:29416952

   CrossRefPubMed
7. 7.↵
   1. Ozgen B,
   2. Oguz KK,
   3. Cila A

   . Diffusion MR imaging features of skull base osteomyelitis compared with skull base malignancy. AJNR Am J Neuroradiol 2011;32:179–84 doi:10.3174/ajnr.A2237 pmid:20947640

   Abstract/FREE Full Text
8. 8.↵
   1. Morabito R,
   2. Alafaci C,
   3. Pergolizzi S, et al

   . DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with CyberKnife. Radiat Oncol 2019;14:65 doi:10.1186/s13014-019-1271-7 pmid:30992043

   CrossRefPubMed
9. 9.↵
   1. Albano D,
   2. Bruno F,
   3. Agostini A, et al

   ; the Young SIRM Working Group. Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging. Jpn J Radiol 2022;40:341–66 doi:10.1007/s11604-021-01223-4 pmid:34951000

   CrossRefPubMed
10. 10.↵
    1. Koontz NA,
    2. Wiggins RH

    . Differentiation of benign and malignant head and neck lesions with diffusion tensor imaging and DWI. AJR Am J Roentgenol 2017;208:1110–15 doi:10.2214/AJR.16.16486 pmid:28245145

    CrossRefPubMed
11. 11.↵
    1. Mouridsen K,
    2. Christensen S,
    3. Gyldensted L, et al

    . Automatic selection of arterial input function using cluster analysis. Magn Reson Med 2006;55:524–31 doi:10.1002/mrm.20759 pmid:16453314

    CrossRefPubMed
12. 12.↵
    1. Kurokawa R,
    2. Kurokawa M,
    3. Baba A, et al

    . Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma. Eur Radiol 2022;32:3672–82 doi:10.1007/s00330-021-08476-7 pmid:35022811

    CrossRefPubMed
13. 13.↵
    1. Prasad SC,
    2. Prasad KC,
    3. Kumar A, et al

    . Osteomyelitis of the temporal bone: terminology, diagnosis, and management. J Neurol Surg B Skull Base 2014;75:324–31 doi:10.1055/s-0034-1372468 pmid:25302143

    CrossRefPubMed
14. 14.↵
    1. Singhal A,
    2. Sotoudeh H,
    3. Chapman PR

    . Skull base osteomyelitis imaging. Curr Opin Otolaryngol Head Neck Surg 2021;29:333–41 doi:10.1097/MOO.0000000000000747 pmid:34459796

    CrossRefPubMed
15. 15.↵
    1. See A,
    2. Tan TY,
    3. Gan EC

    . Atypical culture-negative skull base osteomyelitis masquerading as advanced nasopharyngeal carcinoma. Am J Otolaryngol 2016;37:236–39 doi:10.1016/j.amjoto.2016.01.003 pmid:27178515

    CrossRefPubMed
16. 16.↵
    1. Sokołowski J,
    2. Lachowska M,
    3. Karchier E, et al

    . Skull base osteomyelitis: factors implicating clinical outcome. Acta Neurol Belg 2019;119:431–37 doi:10.1007/s13760-019-01110-w pmid:30840222

    CrossRefPubMed
17. 17.↵
    1. Spielmann PM,
    2. Yu R,
    3. Neeff M

    . Skull base osteomyelitis: current microbiology and management. J Laryngol Otol 2013;127(127 Suppl 1):8–12 doi:10.1017/S0022215112002356 pmid:23089314

    CrossRefPubMed
18. 18.↵
    1. Mahdyoun P,
    2. Pulcini C,
    3. Gahide I, et al

    . Necrotizing otitis externa: a systematic review. Otol Neurotol 2013;34:620–29 doi:10.1097/MAO.0b013e3182804aee pmid:23598690

    CrossRefPubMed
19. 19.↵
    1. Vaidyanathan S,
    2. Lingam RK

    . Imaging of acute and chronic skull base infection. Neuroimaging Clin N Am 2021;31:571–98 doi:10.1016/j.nic.2021.06.002 pmid:34689934

    CrossRefPubMed
20. 20.↵
    1. Ganhewa AD,
    2. Kuthubutheen J

    . A diagnostic dilemma of central skull base osteomyelitis mimicking neoplasia in a diabetic patient. BMJ Case Rep 2013;2013:bcr2012007183 doi:10.1136/bcr-2012-007183

    Abstract/FREE Full Text
21. 21.↵
    1. Surov A,
    2. Meyer HJ,
    3. Wienke A

    . Apparent diffusion coefficient for distinguishing between malignant and benign lesions in the head and neck region: a systematic review and meta-analysis. Front Oncol 2019;9:1362 doi:10.3389/fonc.2019.01362 pmid:31970081

    CrossRefPubMed
22. 22.↵
    1. Baba A,
    2. Kurokawa R,
    3. Kurokawa M, et al

    . ADC for differentiation between posttreatment changes and recurrence in head and neck cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2022;43:442–47 doi:10.3174/ajnr.A7431 pmid:35210272

    Abstract/FREE Full Text
23. 23.↵
    1. Ding X,
    2. Xu H,
    3. Zhou J, et al

    . Reproducibility of normalized apparent diffusion coefficient measurements on 3.0-T diffusion-weighted imaging of normal pancreas in a healthy population. Medicine (Baltimore) 2019;98:e15104 doi:10.1097/MD.0000000000015104 pmid:30946375

    CrossRefPubMed